RIPK1 and chronic obstructive pulmonary disease: However, Chen et al. [56] suggested that NEC-1 does not alleviate cigarette-induced emphysema and airway inflammation, and hypothesized that in COPD, there may exist mechanisms of RIPK3 activation that are independent of RIPK1.